Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.2.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.21EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.21ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.21ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.21EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.21EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.1.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AD.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AD.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AD.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AD.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AD.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AD.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.28ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.28ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1.28EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used